Overview
Qsimulate has secured over $11 million in additional seed financing, led by Embark Ventures. The company, founded by former professors, utilizes a quantum-powered simulation platform to enhance drug discovery, solving complex interactions at the molecular level. Its technology performs simulations 1,000 times faster than traditional methods, attracting demand from major pharmaceutical companies.
Products
Loading...
Recent Deals
Investors: Embark Ventures
Qsimulate has secured over $11 million in additional seed financing, led by Embark Ventures. The company, founded by former professors, utilizes a quantum-powered simulation platform to enhance drug discovery, solving complex interactions at the molecular level. Its technology performs simulations 1,000 times faster than traditional methods, attracting demand from major pharmaceutical companies.